These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22709476)

  • 41. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
    Chang H; Han B; Han XZ
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis.
    Lim BK; Kim JH
    Biol Pharm Bull; 2014; 37(10):1650-4. PubMed ID: 25273388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway.
    Song Y; Ge W; Cai H; Zhang H
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):560-9. PubMed ID: 24057864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
    Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
    Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Fu Q; Gao L; Fu X; Meng Q; Lu Z
    J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The impact of hydrogen sulfide on the heme oxygenase-1/carbon monoxide system in Coxsackie virus B3-induced myocarditis in mice].
    Zhang SY; Wu TT; Ren Y; Xia TH; Wu RZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):765-769. PubMed ID: 29036974
    [No Abstract]   [Full Text] [Related]  

  • 49. GYY4137, a hydrogen sulfide‑releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor‑kappa B and mitogen‑activated protein kinases in Coxsackie virus B3‑infected rat cardiomyocytes.
    Wu Z; Peng H; Du Q; Lin W; Liu Y
    Mol Med Rep; 2015 Mar; 11(3):1837-44. PubMed ID: 25377925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
    Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts.
    Yuan J; Cheung PK; Zhang H; Chau D; Yanagawa B; Cheung C; Luo H; Wang Y; Suarez A; McManus BM; Yang D
    Lab Invest; 2004 Jun; 84(6):703-14. PubMed ID: 15094712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis.
    Yang X; Yue Y; Xiong S
    Front Cell Infect Microbiol; 2019; 9():57. PubMed ID: 30899700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
    Wang D; Chen Y; Jiang J; Zhou A; Pan L; Chen Q; Qian Y; Chu M; Chen C
    Gene; 2014 Sep; 547(2):195-201. PubMed ID: 24905653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance.
    Jin H; Guo X
    Virol J; 2016 Oct; 13(1):168. PubMed ID: 27724948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of FoxO1 on Cardiomyocyte Apoptosis and Inflammation in Viral Myocarditis via Modultion of the TLR4/NF-κB Signaling Pathway.
    Tao DD; Li Y; Tian XJ; Liao XJ; Yu ZQ; Xiang ZY
    Int Heart J; 2023; 64(4):732-740. PubMed ID: 37518354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tranilast inhibits myocardial fibrosis in mice with viral myocarditis].
    Wen C; Xie G; Zeng P; Huang LF; Chen CY
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):446-54. PubMed ID: 27165596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell
    Kraft L; Sauter M; Seebohm G; Klingel K
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C1q/TNF-Related Protein 9 Inhibits Coxsackievirus B3-Induced Injury in Cardiomyocytes through NF-
    Liu K; Wang J; Gao X; Ren W
    Mediators Inflamm; 2020; 2020():2540687. PubMed ID: 33414684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.